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1. Introduction 
Colorectal cancer is the third leading cause of cancer-related mortality in the United States 
and the fourth most common cancer in men and women. Colonoscopy is the best screening 
test done to detect and prevent colorectal cancers. Abnormal growths such as a polyp, a 
tumor, or a suspicious-looking lesion in the colon or rectum can be biopsied or removed 
preventing the initiation of the carcinogenic process and potential metastases into other 
areas of the body, thereby, allowing patients to obtain a more effective treatment (s) with 
fewer side effects. Patients whose cancers are found early and treated in a timely manner are 
more likely to survive than those whose cancers are not found until symptoms appear 
(Atreja, A., Nepal, S. & Lashner, B., 2010; American Cancer Society [ACS], n.d, 2005). Figure 
1 shows a picture of a polyp. Figure 1.a shows a picture of a cancerous tumor of the colon. 
 
         
Fig. 1. Polyp in sigmoid colon                             Fig. 1.a Cancerous tumor in the colon 
The hardest part of the colonoscopy procedure is the preparation. It usually starts one-to-
two weeks prior to the test depending on the recommendation of the physician. Careful 
planning and strict adherence to these instructions is crucial to the success of the test. Many 
individuals who have undergone this procedure will attest to the difficulty in complying 
www.intechopen.com
 
Colonoscopy 
 
4 
with these instructions and the harshness of taking the oral prep. As a result, many are 
hesitant to go through with it risking the possibility of missing diagnoses of cancerous or 
non-cancerous lesions, tumors or polyps in the colon or rectum.  
The key to a successful colonoscopy is good bowel prep, which also depends on the right 
choice of bowel cleansing agent. The colon needs to be totally clean for good visualization to 
avoid missing any abnormal or suspicious-looking areas. A small polyp or lesion can hide 
behind a small piece of stool. Poor or inadequate bowel prep may lead to a prolonged and 
costly procedure and a potentially inaccurate exam. It may also increase the chance of being 
aborted; to be repeated at another time which may be at an interval sooner than what is 
called for or suggested in the standard guidelines. A repeated colonoscopy also increases the 
risks and complications, such as perforation and bleeding of the colon, and infection 
(Lawrence, E. & Pickhardt, P., 2010; Hendry, P., Jenkins, J. & Diament, R., 2007; Froehlich, F., 
et al, 2005). Preparing for colonoscopy may sound complicated, uncomfortable and time-
consuming, but it doesn’t have to be. Following the instructions carefully and being 
prepared ahead of time will help the individual tolerate the procedure with minimal 
discomfort.  
This chapter will discuss the step-by-step process in preparing for this procedure for the 
adult population, explaining the different types of oral preps (including the adjuncts) to take 
as well as diet modification that will achieve the best results, taking into consideration any 
medical condition the individual might have. Special conditions that might be adversely 
affected by the prep, such as diabetes and any heart condition that require taking blood 
thinners will also be discussed. Tips to alleviate the discomfort while taking the prep will be 
outlined as well. The goal is to explain the process in a simple, non-intimidating fashion to 
encourage more individuals to avail of this life-saving screening procedure minimizing any 
fear and anxiety they may have. A well-informed individual is better able to follow 
directions carefully to ensure good results. Figure 2 shows an adequately clean transverse 
colon. 
 
 
Fig. 2. Transverse Colon 
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2. Bowel cleansing preps 
Some key questions need to be answered prior to selecting an appropriate bowel cleansing 
agent for the individual:  
1. Does the individual have any condition (s) that is contraindicated to taking a bowel 
prep (i.e. bowel obstruction, perforation, and severe ileus)? If the answer is “yes,” then 
another alternative diagnostic exam need to be considered. 
2. Is the individual at risk for fluid and/or electrolyte imbalances? If the answer is “yes,” 
then avoid the sodium phosphate group. Choose the polyethylene glycol. 
3. Can the individual tolerate full volume solutions? If not at risk for fluid and electrolyte 
imbalance and cannot tolerate large doses, choose low-volume polyethylene glycol or 
sodium phosphate. Sodium picosulfate and magnesium citrate can also be another 
alternative to sodium phosphate. This is the choice in most European countries and is 
currently not available in the United States (Atreja, A., Nepal, S. & Lashner, B., 2010). 
Otherwise, a 4-L polyethylene glycol solution is the choice especially if the individual 
has a history of poor bowel prep or is worried about cost or insurance coverage. 
Compliance to completing a bowel prep is also dependent on a number of factors, namely, 
poor palatability of the prep, concomitant medications, comorbitites affecting renal and 
hepatic functions, time of test i.e. early morning or late in the afternoon, sex, and cost 
(Atreja, A., Nepal, S. & Lashner, B., 2010 & ASGE, 2009). Colonoscopies performed in the 
afternoon have shown higher rates of poor bowel prep and lower rates of adenoma 
detection (Varughese, S., Kumar,A.,George, A., & Castro, F., 2010; Sanaka,M., Shah,N., 
Mullen,K. et al,2006; Ness,R., Manam, R., Hoen,H. et al, 2001). One study found males to 
have poorer preps than females and the authors recommended these individuals schedule 
their colonoscopies in the afternoon to take advantage of the split-dosage regimen. The 
authors also found that colonoscopies performed within 6-8 hours of the end of the bowel 
prep resulted in a better cleansing than those performed more than 8 hours after ingestion of 
the last prep dose (Marmo, R., Rotondano, G., Riccio, G. et al. 2010). 
The criteria for good bowel prep include: 
• Require a short period of ingestion and the ability to empty out the colon in a rapid 
fashion without grossly or microscopically altering the lining of the colon 
• Will not cause undue shifts in fluid and electrolyte balances 
• Are safe to administer in light of existing comorbidities 
• Easy to complete regimen 
• Reimbursed by health insurance company or is inexpensive 
Unfortunately, none of the preparations currently available on the market meet all these 
criteria. As a result, several adjunctive methods have been added along with the main prep 
and are now available on the market to make it easier and tolerable for the individual to 
take (Lawrence, M. & Pickhardt, P., 2010).  
Historically, bowel cleansing agents evolved from preparations prior to surgical and 
radiologic exams. These included enemas, ingestion of cathartics as well as dietary 
restriction of low residue diet for 2-3 days prior to the procedure (Wexner, S., et al. 2006). 
These were harsh regimens which were time consuming, uncomfortable and inconvenient 
for the patient; hence, compliance was difficult. In addition, the early preparations 
contained mannitol, which, when fermented by bacteria in the colon resulted in combustible 
methane and hydrogen, which created a high risk for gas explosion when cautery was used. 
This was also true for sorbitol preparations (ASGE, 2009). This led to the development of an 
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osmotically balanced solution with minimal water absorption or secretion into the colon by 
Davis and his colleagues in the 1980s (Davis, 1980). The solution was polyethylene glycol, “a 
high-molecular weight, nonabsorbable polymer in a dilute electrolyte solution that has an 
osmotic effect on the colon (Atreja, A., Nepal, S. & Lashner, B., 2010).” There are several 
commercially prepared bowel cleansers, and the compounds used in these preps generally 
fall into three major groups according to their mechanism of action: isosmotic (the 
polyethylene glycol group), hyperosmotic (the sodium phosphate group), and bowel 
stimulants (Atreja, A., Nepal, S. & Lashner, B., 2010; ASGE, 2009; Barkun, A. et.al, 2006; 
Wexner, S., Beck, D., Baron, T., et al., 2006). Other preparations have since been introduced 
to improve palatability and compliance, e.g. low volume prep such as PEG and Bisacodyl 
(Halflytely) and PEG and ascorbic acid (MoviPrep). The most commonly used bowel 
preparations in the United States are the oral sodium phosphate (NaP) solutions and the 
polyethylene glycol (PEG) solutions (Atreja, A., Nepal, S. & Lashner, B., 2010 & ASGE, 2009; 
Barkun, A., Chiba, N., Enns, R., et al., 2006). A summary is shown on Table 1.  
 
Product Active Ingredient
Approved 
Bowel Prep By 
FDA for Adults
Approved 
Bowel Prep by 
FDA for 
Pediatrics 
Amount 
Isosmotic FV*     
Colyte ( Flavored 
& Nonflavored) 
Polyethylene 
Glycol (PEG) 
Yes No 4000 ml (4L) 
GoLYTELY 
(Flavored & 
Nonflavored) 
Polyethylene 
Glycol (PEG) 
 
Yes 
No 4000 ml (4L) 
TriLyte 
(Flavored) 
Sulfate-free 
Polyethylene 
Glycol  
Yes >6 months 4000 ml (4L) 
NuLYTELY 
(Flavored & 
Nonflavored) 
Sulfate-free 
Polyethylene 
Glycol
Yes >6 months 4000 ml (4L) 
Isosmotic LV**     
                            
MoviPrep 
PEG & Ascorbic 
Acid 
Yes No 2000 ml (2L) 
Halflytely PEG & Bisacodyl  Yes No 
4 Bisacodyl 
Delayed-Release 
tablets plus 
2000 ml (2L) 
PEG 
Glycolax 
PEG-3350 without 
electrolytes 
No No 255 grams 
Miralax 
PEG-3350 without 
electrolytes 
No No 255 grams 
Hyperosmotic     
Osmoprep 
Sodium phosphate 
(oral) 
Yes + No 32 tablets 
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Visicol 
Sodium phosphate 
(oral) 
Yes + No 40 tablets 
Fleet Enema 
Sodium phosphate 
(enema) 
Yes + >12 years 135 ml 
Magnesium 
Citrate 
Magnesium citrate 
(oral) 
Yes >6 years 300 ml 
Fleet Phospho-
Soda EZ-Prep 
Sodium phosphate 
(oral) 
Available as 
prescription 
only+ 
No 75 ml 
LoSoPrepKit 
Magnesium citrate 
plus Bisacodyl oral 
& suppository 
Yes No One package 
Picolax 
Sodium 
picosulfate & 
magnesium citrate 
No. Available 
only in Europe 
& UK 
Yes 
Two sachets 
dissolved in 300 
ml solution 
CitraFleet 
Sodium 
picosulfate & 
magnesium citrate 
No. Available 
only in Europe 
& UK 
No 
Two sachets 
dissolved in 300 
ml solution 
Stimulant 
laxatives 
    
Picolax # 
Sodium 
picosulfate & 
magnesium citrate 
No. Available 
only in Europe 
& UK 
Yes 
Two sachets 
dissolved in 300 
ml solution 
CitraFleet# 
Sodium 
picosulfate & 
magnesium citrate 
No. Available 
only in Europe 
& UK 
No 
Two sachets 
dissolved in 300 
ml solution 
Senna Senna No No 100 tablets 
*Full Volume +Black Box warning included  # Classified as osmotic and stimulant laxative  
**Low Volume +FDA recommends against over-the-counter use 
Table 1. Commonly Used Bowel Preparation Agents 
2.1 Isosmotic or the polyethylene glycol group 
Polyethylene glycol solutions are nonabsorbable fluids that act as purgatives to evacuate 
the colon of stool. These are high volume gut lavage solutions that are osmotically 
balanced and do not induce a significant electrolyte and fluid shifts, hence, are more 
effective, better tolerated, and safer for individuals who have advanced liver or kidney 
disease, poorly compensated congestive heart failure, or have documented electrolyte 
imbalances. These also do not cause significant physiologic changes in the individual’s 
vital signs, weight, and blood counts. However, some rare adverse events have been 
reported in association with polyethylene glycol ingestion. These include Mallory-Weiss 
tear, esophageal perforation, colitis, cardiac dysrhythmias, hyponatremia, aspiration, 
pancreatitis, and a syndrome of inappropriate antidiuretic hormone secretion 
(Lichtenstein, G., Cohen, L. & Uribarri, J., 2007). Commercially prepared polyethylene 
glycol solutions come in full volume: flavored and unflavored GoLYTELy, flavored and 
unflavored Colyte, NuLytely (sulfate-free), Trilyte flavored (sulfate-free); and low 
volume: Halflytely and MoviPrep (ASGE, 2009). 
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The standard large volume polyethylene glycol (PEG) solutions, Colyte and GoLYTELY 
have been studied extensively and were found to have the most evidence for safety and 
effectiveness. The sodium sulfate in PEG allow for a reduction in sodium absorption in the 
small intestine. These solutions are also inexpensive and most health insurance companies 
reimburse the cost. The conventional adult dose is 4L, given as 240ml of the solution every 
10 minutes 12-15 hours prior to the procedure until the 4L is consumed and rectal output is 
clear and watery. If given through a nasogastric tube, 20 to 30ml is instilled every minute. 
However, because of the large volume required to cleanse the colon and its poor palatability 
(salty taste and smell of sulfates), about 15% of individuals do not complete the prep (Atreja, 
A., Nepal, S. & Lashner, B., 2010 & Wexner, S., Beck, D., Baron, T., et al., 2006). The main 
complaint was nausea, bloating, abdominal cramping, and vomiting. To remedy this, 
splitting the dose allowed for better compliance and tolerability by the patients; half the 
dose was ingested the night before the procedure and the other half taken 4-5 hours prior to 
the procedure (Marmo, R., Rotondano, G., Riccio, G. et al, 2010). This method resulted in a 
better cleansing of the colon. With the traditional method of single dosing, the long interval 
between the end of the prep and the start of the procedure allowed secretions from the small 
intestine to flow into the large intestine, obscuring the view of the cecum and ascending 
colon. A study conducted by Varughese and associates found that for colonoscopies 
scheduled in the afternoon, ingestion of the one gallon or 4 L solution of polyethylene glycol 
resulted in superior cleansing of the colon and was better tolerated by the study 
participants. There were fewer side effects, too. This method evacuated the contents of the 
large intestine in a timely manner and did not allow time for the contents of the small 
intestine to flow to the large intestine thereby obscuring the view (Varughese, S., 
Kumar,A.,George, A., & Castro, F., 2010). Stimulant laxatives or ascorbic acid were also 
added to low-volume PEG solutions (e.g. MoviPrep) to improve compliance and palatability 
(Atreja, A., Nepal, S. & Lashner, B., 2010). 
Other suggestions to make ingestion of PEG solutions more tolerable are: 
• Adding flavor enhancers, such as Crystal Light, Gatorade, lemon juice or lemon slices. 
• Chilling the solution or adding ice cubes and drinking through a straw.  
• Taking metoclopramide (Reglan) 5-10mg tablets prior, to prevent nausea. 
• Adding one bottle of magnesium citrate (about 300 ml) or two to four tablets of 
bisacodyl 5mg/tab to decrease the volume ingested. 
• Stopping ingestion of the prep once the stool is clear and watery on the day of the test. 
• Administration of the prep via a nasogastic tube for individuals with altered mental 
status or with swallowing disability. 
• Ingestion of sulfate-free or flavored PEG solutions, such as NuLytely and TriLyte 
(flavors come in cherry, pineapple, orange, lemon-lime, and citrus-berry). 
• Ingestion of a low-volume solution (2 liters) plus a stimulant laxative, e.g. HalfLytely 
with two bisacodyl tablets and magnesium citrate; MoviPrep which is PEG plus 
ascorbic acid. 
A sulfate-free PEG solution was developed by Fordtran et al in the 1990s to improve 
palatability and smell of PEG solutions. The improved taste is the result of a decreased 
amount of potassium, increased amount of chloride and no sodium sulfate. Examples of 
these products are NuLYTELY and TriLyte and come in different fruit flavors. Dosing is the 
same as the 4L PEG solution. It is comparable in terms of safety, tolerance, and effectiveness 
to the conventional PEG solutions (Wexner, S., Beck, D., Baron, T., et al. 2006). Low-volume 
 
www.intechopen.com
 
Preparing for Colonoscopy 
 
9 
              
 
                      
Fig. 3. Several commercially prepared polyrethylene glycol solutions:  
Top left, GoLytely; top right, HalfLytely.  
Bottom left, Colyte and bottom right, MoviPrep. 
PEG preparations (e.g. PEG + ascorbic acid, PEG + electrolytes) were developed to improve 
patient tolerance by reducing the amount of solution required, and thus, reducing volume-
related symptoms such as nausea, bloating, and abdominal cramping. Studies have shown 
equal efficacy with full volume PEG solutions but with improved compliance and tolerance 
by patients (Ell, C., Fischbach, W., Bronisch, H. et al. 2008; Bitoun, A., Ponchon, T., Barthet, 
M. et al., 2006; DiPalma, J., Wolff, B., Meagher, A. & Cleveland, M., 2003).  
2.2 Hyperosmotic or the sodium phosphate solutions 
Sodium phosphate is widely used worldwide and is an effective bowel cleansing agent. It is 
better tolerated than PEG preps due to its smaller volume (1.5 -2 liters compared with 
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polyethylene glycol’s 4 liters) and better flavor. Its hyperosmotic property draws water into 
the colon stimulating peristalsis and eventually affecting a bowel movement. Unfortunately, 
this is the main disadvantage of NaP solutions, because it causes major fluid and electrolyte 
shifts in the body, such as hyperphosphatemia, hypocalcemia, hypokalemia, hyponatremia 
and/or hypernatremia, hypovolemia and increased plasma osmolality. This may lead to an 
acute phosphate nephropathy in patients with renal failure (ASGE, 2009; Balaban, D., 2008; 
Khurana, A., McLean,L, Atkinson, S. et al., 2008; Curran, M. & Plosker, G., 2004). Sodium 
phosphate solutions are therefore, not recommended in individuals with congestive heart 
disease, bowel obstruction, hepatic and renal disease, ascites, and megacolon. The following 
may also be at risk of injury to the kidneys if prescribed NaP: individuals over the age of 55, 
patients who are already dehydrated, patients with acute colitis, individuals taking 
diuretics, ACE (angiotensin converting enzyme) inhibitor drugs, ARB (angiotensin receptor 
blockers), and non-steroidal anti-inflammatory drugs (NSAIDS) (Ker, T., 2006; Hookey, L., 
Depew, W. & Vanner, S., 2002). A study done by Yakut and his associates found that in a 
selected group of elderly patients without comorbidities such as heart, kidney and liver 
failure, and diabetes, the administration of NaP preparation for colonoscopy was safe and 
well tolerated, with a low frequency of side effects (Yakut, M., Kubilay, C., Gülseren, S. et 
al., 2010). Dong Choon and associates conducted a retrospective study between August of 
2005 and May of 2008 in patients with normal kidney function, undergoing colonoscopy at a 
health center in Korea using NaP solution as the bowel cleansing agent and found that it 
was safe and effective and no untoward renal injury was noted (Dong Choon, S., Sung Noh, 
H., Jeong Hwan, K. et al. 2010). Abaskharoun and colleagues also corroborated this findings 
with their own retrospective study in a Canadian health center (Abaskharoun, R., Depew, 
W. & Vanner, S., 2007). A prospective study by Casais et al. found that hyperphosphatemia 
in low-risk individuals was related to low weight and can be minimized with adequate 
hydration. It was their recommendation to prescribe an appropriate NaP dose according to 
the individual’s weight (Casais, M., Guillermo, R-D., Perez, S, et al., 2009). In December 
2008, the Federal Drug Administration (FDA) has recommended NaP preparations be 
removed as an over-the-counter bowel prep to avoid inappropriate use or overdosing, and a 
black box warning be included in the labels of  prescription products warning consumers of 
the risk of acute phosphate nephropathy. C.B. Fleet Company voluntarily recalled its oral 
NaP products, Fleets Phospho-Soda and Fleet EZ-PREP. Sodium phosphate comes in tablet 
form or aqueous solution. The tablet form, Visicol and OsmoPrep, are the only two sodium 
phosphate prep available in the United States. The aqueous solution is no longer available 
(US FDA, 2008; Ainley, E., Winwood, P. & Begley, J., 2005). Figure 4 shows examples of 
sodium phosphate products available in the market. 
The differences in efficacy and safety of PEG and NaP solutions in cleansing the bowel prior 
to colonoscopy have been studied extensively, and, in general, the histology of the normal 
colon has been shown to be preserved with PEG solutions. 
Sodium phosphate solutions can alter the macroscopic as well as the microscopic 
appearance of the mucosa of the colon mimicking inflammatory bowel diseases. Thus, these 
preps are to be avoided in individuals with or suspected with colitis or inflammatory bowel 
diseases (Bucher, P., Gervaz, P., Egger, J., et al., 2006; Rejchrt, S., Bures, J., Siroky, M. et al. 
2004). 
Magnesium Citrate is a saline laxative and also a hyperosmotic, and like sodium phosphate, 
acts by drawing water into the colon. Since it contains magnesium, and elimination is 
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Fig. 4. Sodium phosphate products available in the US: OsmoPrep and Visicol. The aqueous 
formula is available only as a prescription. 
through the kidneys, administer with extreme caution in individuals with renal 
insufficiency or failure (Atreja, A., Nepal, S. & Lashner, B., 2010). Magnesium citrate is often 
used as an adjunct to bowel prep. In addition to the PEG solution, adding magnesium 
citrate to the prep reduces the amount of PEG solution required to 2L. Taken the night 
before the procedure (one 300 ml bottle of magnesium citrate) plus two bisacodyl tablets 
and 2L of PEG solution, has shown to be just as effective as taking the full dose of PEG 
solution. Used alone, magnesium citrate is not an effective bowel cleansing agent prior to 
colonoscopy procedures. Magnesium citrate is often used as an adjunct to bowel prep 
(Atreja, A., Nepal, S. & Lashner, B., 2010; Wexner, S., Beck, D., Baron, T., et al., 2006). 
                                                               
 
Fig. 5. Magnesium Citrate bottle 
2.3 Stimulant preparations 
Stimulant laxatives such as bisacodyl (Dulcolax) have been added to low volume PEG 
solutions and have achieved comparable results to those given the standard dose of PEG 
solutions (Atreja, A., Nepal, S. & Lashner, B., 2010). It is poorly absorbed in the small 
intestine and its active ingredients stimulate colon motility, with an onset of action between 
6-10 hours (ASGE, 2009).  
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Fig. 6. Dulcolax tablets 
Sodium picosulfate is another cathartic with osmotic action on the bowel similar to NaP. It 
is a saline laxative used in combination with magnesium citrate. An observational study 
done in Canada by Love and his colleagues found that administration of sodium picosulfate 
and magnesium citrate yielded a high percentage positive rate for efficacy (Yakut, M., 
Kubilay, Ç., Gülseren, S. et al., 2010). This preparation is mostly used in Europe and Canada 
and is not available in the United States (ASGE, 2009). 
 
 
     
Fig. 7. Sodium picosulfate products. Not available in the US 
Senna, an anthracene derivative also helps stimulate colon peristalsis by increasing smooth 
muscle wall activity. A low dose senna (four 8.6 mg tablets of Sennakot) added to a low-
volume solution of polyethylene glycol have been found to be just as effective as taking the 
full-volume PEG solution. It is usually taken within 2 to 6 hours of starting the PEG 
solution. A study found that there was better visualization of the right colon when senna 
was added to the magnesium citrate prep and was also better tolerated by the subjects 
(Vradelis, S., Kalaitzakis, E., Sharifi, Y. et al 2009). 
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Fig. 8. Senna products                        
2.4 Adjunct bowel preparation agents 
Enemas are useful in cleansing the distal colon in preparation for a sigmoidoscopy, but not 
recommended as prep for a full colonoscopy. They are used as adjuncts when patients come 
poorly prepped. The common types are: tap water enemas, soap suds enemas, sodium 
biphosphate (Fleet), and oil-based enemas such as, cottonseed oil plus docusate (Colace) and 
diatrizoate sodium (Hypaque). The last one is an iodinated water-soluble contrast agent 
used in radiographic exams that has a cathartic property. It slows absorption of water from 
the bowel so that the stool is softer. One study found that combining diatrizoate sodium 
with a low-volume saline laxative prep (preferably magnesium citrate) was just as effective 
as, if not better, than the other regularly prescribed preps. It consistently outperformed the 
standard high-volume PEG solutions in terms of effectiveness as a bowel cleanser and 
patient compliance and tolerance (Lawrence, E. & Pickhardt, P., 2010). One disadvantage to 
using this prep was that some individuals developed severe allergic reactions such as 
anaphylaxis and angioedema. Others have experienced muscle cramps and intermittent 
leakage of stool in their undergarments for up to 24 hours after the test (Atreja, A., Nepal, S. 
& Lashner, B., 2010; Lawrence, E. & Pickhardt, P., 2010 & Sohn, N. & Weinstein, M., 2008; 
Wexner, S., Beck, D., Baron, T., et al., 2006). 
Dietary modifications alone are inadequate prep for colonoscopy, but are a beneficial adjunct, 
by decreasing the formation of solid residue. Drinking clear liquids is recommended in ALL 
bowel preps and helps maintain adequate hydration (Atreja, A., Nepal, S. & Lashner, B., 2010; 
ASGE, 2009; Dykes, C. & Cash, B., 2007; National Guideline Clearinghouse, 2006). 
Carbohydrate-electrolyte solutions such as Gatorade and E-Lyte have been added to both 
PEG and NaP solutions to improve palatability and to avoid severe fluid and electrolyte 
shifts (Wexner, S., Beck, D., Baron, T., et al., 2006). 
Antiemetic agents such as metoclopramide (Reglan 5-10mg) are commonly used to prevent 
nausea and vomiting associated with taking bowel preparations. 
Antifoaming agents, such as Simethicone (three 80 mg tablets), an anti-gas, anti-flatulent 
agent, has been added to the prep to reduce the bubbles and improve visibility during 
colonoscopy (Tongprasert, S., Sobhonslidsuk, A. & Rattansiri, S., 2009). 
Nasogastric or orogastric tube installation is usually reserved for inpatients that are unable 
to drink the polyethylene glycol solutions, for patients who are unresponsive or those on 
mechanical ventilators. 
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Rectal Pulsed Irrigation administered immediately prior to the colonoscopy preceded by 
intake of magnesium citrate the night before is also another alternative, though this is time 
consuming, expensive and requires expert nursing skill to be efficiently performed  
(Wexner, S., Beck, D., Baron, T., et al., 2006). 
Clebopride is another adjunct that has gained some interest among endoscopists. It is a D-2 
dopamine antagonist with antiemetic and prokinetic properties which can improve the 
efficacy of bowel cleansing. A study was done to evaluate the efficacy, safety, tolerability, 
and acceptance of Clebopride as an adjunct to PEG solution as prep for colonoscopy. The 
authors found that Clebopride was better accepted by patients and was better tolerated as 
well. It diminished the symptom of nausea, abdominal distention, and borborygmus 
(Abdullah, M., Aziz Rani, A., Fauzi, A. et al., 2010). 
3. Special considerations 
Diabetes Mellitus. Diabetic patients need to follow certain pre- and post- colonoscopy 
instructions to prevent hyper- or hypoglycemia episodes. The individual needs to discuss 
his/her medications with the physician at least two weeks prior to the test. Individuals 
taking insulin may need to have their regular dosages adjusted the day before and the day 
of the procedure. See tables 2 and 3 for general guidelines. 
Cardiac conditions. Individuals taking blood thinners will need to consult their physician as 
to when to stop taking these medications prior to colonoscopy. A blood test to check the 
PT/INR will need to be drawn in the morning the day before the exam. He or she should 
not stop taking his or her other cardiac medications without consulting his or her physician. 
Blood pressure medications are generally allowed to be taken even on the day of the 
procedure. 
The elderly. The elderly often have poorer bowel preps which may be attributed to a decrease 
or alteration in intestinal motility secondary to the aging process or other comorbidities. 
Constipation contributes to the poor quality of the colonoscopy which may be associated 
with the elderly’s sedentary lifestyle, inadequate intake of fiber, depression, and dementia 
(Yakut, M., Kubilay, Ç., Gülseren, S. et al., 2010). They are also at risk for fluid and 
electrolyte imbalance, especially phosphate intoxication, due to concomitant medication use, 
comorbidities, poor kidney function or other gastrointestinal disorders. Adequate hydration 
without compromising cardiac function is of utmost importance with this population. 
Pregnancy. The need for colonoscopy during pregnancy is rare, hence the safety and efficacy 
of the bowel preps have not been studied. If it is deemed that the potential benefit of 
colonoscopy outweigh the small, but possible risks, then the pregnant woman may be 
cleansed with PEG solutions. NaP preps may be used with caution in select patients (ASGE, 
2009; National Guideline Clearing House, 2006). 
The pediatric population will be discussed in another chapter. 
4. Colonoscopy bowel preparations: general patient instruction guidelines 
Two weeks prior to your procedure: 
• You need to speak with or see the physician who will be performing your colonoscopy 
to go over your medical and surgical history, medications you take on a regular basis, 
allergies, any other pertinent information relevant to your procedure or concerns you 
may have. For women, please let the physician know if you are pregnant or maybe 
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pregnant. If you have kidney or liver disease and are on fluid restriction, your prep and 
diet may need to be adjusted. 
• Your physician will advise you what medications you need to discontinue and when to 
discontinue these prior to the test. These include all types of blood thinners or 
antiplatelet medications, anti-inflammatory drugs, multivitamin with iron and any 
other medication containing iron preparation, and bulk-forming agents. 
• If you have diabetes, it is advisable to schedule an appointment early in the day so that 
you can eat after and take your medications as close to your usual time as possible. You 
will be asked to bring your blood glucose meter and test strips and any treatment you 
use when you experience low blood sugar levels on the day of the exam. 
• For asthma sufferers, you need to bring your inhaler (s) the day of the exam.  
• For individuals using a CPAP or BiPAP machines, you will be asked to bring these on 
the day of the exam as well. 
• You will be asked to arrange for a ride to your colonoscopy as you will not be 
allowed to drive a car, take the bus or taxi home after the procedure. You will be 
given sedation medications for the procedure and the effects usually linger for a few 
hours after the test is completed. You will spend about 1-2 hours in the endoscopy 
suite, which includes the pre-procedure prep, the colonoscopy itself, and post-
procedure recovery time. You will go home after to rest and allow the rest of the 
sedatives to wear off. If you arrive without an escort, your test will be cancelled or 
rescheduled. 
Seven days prior to your procedure: 
• Stop taking the following medications:  
• Iron, vitamin E and medications containing either component 
• Garlic, Ginko Biloba, ginger 
• Blood thinners (anticoagulant) such as warfarin (Coumadin), Fondaparinux 
(Arixta), enoxaparin (Lovenox) 
• Antiplatelets such as prasugrel (Effient), clopidogrel (Plavix), cilostazol (Pletal), 
anagrelide (Agrylin), pentoxifyline (Trental), dipyridamole (Persantine), 
dipyridamole with aspirin (Aggrenox), aspirin and any other products containing 
aspirin (Anacin, Alka Seltzer, Bufferin). 
Note: You must have your PT/INR checked in the morning the day before your test if you 
are on Coumadin or Warfarin, Plavix or Jantovan. 
Five to three days prior to your test: 
• Confirm your ride. 
• If you need to cancel or reschedule your appointment, this is the time to do so. Call the 
office where you booked your appointment. 
• Review the diet you need to follow as well as medication schedule if you are a diabetic. 
Most heart medications  such as ones for high blood pressure are generally allowed to 
be taken even on the day of the exam. Diuretic  medications are usually asked to be 
taken after the procedure is completed. 
• Purchase your prescription bowel prep, but DO NOT MIX  or PREPARE the solution 
until the day before the exam, if not taking the pill form. 
• Stop taking bulk-forming agents such as Metamucil or Citrucel. 
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Two days before the procedure: 
• Stop taking ALL anti-inflammatory drugs such as ibuprofen and ibuprofen products 
(Advil, Motrin, Nuprin), Voltaren, naproxen (Aleve, Anaprox, Midol Extended Relief, 
Naprelan, Naprosyn), Indocin, Relafen, Voltaren. Acetaminophen (Tylenol) is okay to 
take for any headache or discomfort you might be experiencing. 
• Stop eating seeds, nuts, corn, popcorn, whole grains. 
• Drink a minimum of eight glasses of water throughout the day. 
• Do not eat any solid food after midnight. 
Day before the procedure: 
• Beginning at breakfast, DO NOT EAT ANY SOLID FOOD. Instead, start a clear liquid 
diet which means drinking liquids that you can see through, e.g. apple juice, white 
grape juice, ginger ale, lemon-lime soda, Gatorade, Kool-Aid, Jello, coffee (without the 
creamer), tea, Seltzer, broth, bouillon or consommé. Do not drink liquid that is red, 
blue, or purple (cherry, purple grape, or berry flavors). Also avoid milk, milk 
products, non-dairy creamers, or alcohol. 
•     For diabetics, the following are suggested clear food choices: 
• Apple juice (4 oz.)                                                                            15 Gm carbohydrate 
• Plain Jello without fruit (regular sweetened, ½ C.)                    15  Gm carbohydrate 
• Grape juice (white, 4 oz.)                                                                20  Gm carbohydrate 
• Any sports drink such as Gatorade (8 oz.)                                   15  GM carbohydrate  
• Italian Ice                                                                                           3 0 Gm carbohydrate 
• Ice pops, orange or yellow popsicles                                              15 Gm carbohydrate 
• Coffee or tea with 1 tsp. sugar (one packet)                                  4   Gm carbohydrate 
• Fat-free beef or chicken broth, bouillon or consomme´                      no carbohydrate 
• Clear diet soda, such as ginger ale                                                         no carbohydrate 
• Seltzer (flavored or nonflavored)                                                           no carbohydrate 
• Flavored water                                                                                          no carbohydrate 
• Tea with slice of lemon 
*Note: Aim for 45 grams of carbohydrate during mealtimes and 15-30 grams for snacks. 
Read the label of commercially prepared drink items for carbohydrate measurement per 
serving. Refer to Table 2 for diabetic medication guidelines. 
• In addition to water, drink a variety of liquid throughout the day (recommended every 
hour while awake). Your body needs a combination of water, sugar, and electrolytes. It 
will keep you from being dehydrated, weak, and hungry and you will be better able to 
tolerate the bowel prep. A new product on the market, called Colonoscopy Prep 
Assistant, helps individuals keep track of their hydration status. It is a web application 
that tracks the number of glasses of fluid the patient has taken, the time interval 
between drinks, and notifies the patient when it’s time to take the next glass of fluid. 
This application is available for free in the Android market and iTunes and can also be 
downloaded at www.wellapps.com. 
• For individuals taking polyethylene glycol (PEG) prep, do the following: 
• In the morning, mix the PEG solution as directed and refrigerate. 
• Around 1:30 PM, take one tablet of metoclopramide (Reglan), if prescribed, to 
prevent or relieve the nausea that accompanies ingestion of the PEG solution. 
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Medications Morning Lunch Dinner/Supper Bedtime 
Actos, Actoplus 
Met, Avandamet, 
Avandia, 
Metformin, 
Janumet, and 
Januvia 
Take your usual 
dose 
Take your usual 
dose 
Take your usual 
dose 
 
Amaryl, 
Avandaryl, 
Duetact, 
Glipizide, 
Glucovance, 
Glyburide, 
Metaglip, 
Prandin, and 
Starlix  
Do not take Do not take   
Humalog, Regular 
or Novolog 
Insulin 
If prescribed a 
fixed dose, take 
½ the regular 
amount   OR 
cover your carbs 
with usual carb 
ratio 
If prescribed a 
fixed dose, take 
½ the regular 
amount   OR 
cover your carbs 
with usual carb 
ratio 
  
Lantus or NPH 
Insulin 
Take your usual 
dose 
 
 
 
Take your 
usual dose 
 Novolog Mix  
70/30, Novolin 
70/30, Premixed 
insulin75/25 
Take half the 
usual dose at 
breakfast 
 
Take half the usual 
dose at dinner time
 
Table 2. General guidelines for diabetic medications the day before colonoscopy 
       
Fig. 9. Varieties of clear liquid: broth, Jello, apple juice or white grape juice, Gatorade, and 
ginger ale                          
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• If prescribed the 4-L GoLytely, take one glass (8 oz) every 15-20 minutes half-an-
hour after taking the metoclopramide tablet, until half gallon is gone. Remember to 
drink clear liquids or water in between until you go to bed. Be sure to stay close to 
the bathroom. The rest of the half gallon will be taken the next day, about 3-4 hours 
prior to the scheduled procedure. If you have a morning appointment, you may 
need to get up in the middle of the night to complete your prep. If your test is in 
the afternoon, you may start taking the rest of the prep at 6 AM, one glassful every 
15-20 minutes until the half gallon is consumed. 
• If nausea continues, take a second tablet of metoclopramide around 5 or 6 PM. Let 
your physician know if you are having difficulty completing the prep or 
uncomfortable side effects such as nausea, vomiting continues. 
• Another approach would be to take 3L the night before and 1L the day of the 
procedure. 
• For low-volume PEG preparations plus bisacodyl tablets, the clear liquid diet the day 
before is also followed.  
• Around noon time, take four (5mg) bisacodyl delayed-release tablets.  
• Start taking the PEG solution after a bowel movement occurs following taking the 
bisacodyl tablets. Keep drinking a glassful of the prep every 10-15 minutes until the 2 
liters is consumed. You may take a break in-between dose if bloating, nausea, or 
vomiting ensues. Resume after the symptom (s) subsides. 
• For low-volume PEG prep (MoviPrep) with magnesium citrate, do the following: 
• Upon waking up the day before the exam, prepare the solution by mixing pouches 
1 & 2 into the disposable container provided. Add lukewarm to the top line and mix 
until completely dissolved. Refrigerate. At around 5 PM, start drinking a cupful of the 
solution (about 8 oz.) down to the first mark on the container. Make sure you follow this 
with clear liquid of your choice. Keep drinking the solution down to the next line and so 
forth every 15 minutes until the liter is consumed. 
• The process will be repeated again for dose #2, but will not be taken until around 
7:30 PM the same evening. 
• For individuals taking the sodium phosphate (NaP) prep, do the following: 
• Only clear liquids are consumed the day before the procedure. 
• For the aqueous NaP prep, take a 30 to 45 ml solution with at least 8 oz. of water 
(or any other preferred clear liquid) 10-12 hours prior to your scheduled exam. The 
second dose will be ingested at least 3-4 hours prior to your test the next day. 
• Continue to drink clear fluids until you go to bed. 
• Another recommended approach is to take the two doses of NaP, three hours apart 
in-between dose, starting at 4 PM or 5 PM for the first dose followed by the second 
dose around 9 PM, and supplemented around 10 PM by four bisacodyl (5mg) 
tablets. 
• For individuals prescribed the pill form (Osmo-Prep or Visicol: The recommended 
dose is 3 tablets every 15 minutes for 6 doses and then 2 tablets for a total of 20 
tablets, the day before the procedure. This is again repeated the next day, 3 to  
5 hours before the scheduled test. Osmo-Prep uses only 32 tablets in divided  
doses similar to Visicol. Again, these are taken with water or clear liquid. Dulcolax 
or magnesium citrate may also be added as an adjunct to ensure clear bowel  
return. 
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Tips: Do not be surprised if you do not have a bowel movement soon after ingesting your 
prep. It usually takes about 2-4 hours before you have your first bowel movement. Stay 
close to the bathroom as you will spend most of your day on the toilet. Try to use moistened 
wipes or a water spray instead of toilet paper to clean yourself to minimize irritation of the 
anal area. If you have a colostomy, be prepared to empty out your pouch often and liquid 
stool may leak around your pouch as well. Remember to keep drinking plenty of clear 
liquids to prevent dehydration. Follow your  instructions for the prep as you do not want to 
repeat this procedure all over again because you did not get it right the first time. 
Day of the procedure: 
• Take your regular medications allowed by the physician with a small sip of water. You 
may have clear liquids three hours before your test. Refer to Table 3 for medication 
guidelines if you are a diabetic and remember to check your blood sugar in the morning 
before coming to the colonoscopy. Also bring your glucometer, extra test strips and 
your treatment for any hypoglycemic (low blood sugar) episodes. 
• Have your driver drive you to the colonoscopy place half-an-hour before your scheduled 
procedure or whatever time you were instructed to arrive. Remember to bring your paper 
work, medications, inhalers, CPAP or BiPAP machine, and health insurance card. 
• Make sure you wear comfortable clothing and bring extra clothes, underwear or peri-
pads in case you have an accident and soil your clothes or underwear. 
 
Medications Morning Lunch Dinner/Supper Bedtime 
Actos, Actoplus 
Met, Avandamet, 
Avandia, 
Metformin, 
Janumet, and 
Januvia 
Take your usual 
dose 
Take your usual 
dose 
Take your usual 
dose 
 
Amaryl, Avandaryl, 
Duetact, Glipizide, 
Glucovance, 
Glyburide, 
Metaglip, Prandin, 
Starlix  
Do not take 
Resume 
regularly 
prescribed dose 
if allowed to eat
  
Humalog, Regular 
or Novolog Insulin 
Do not Take 
Resume 
regularly 
prescribed dose 
if allowed to eat
Resume regularly 
prescribed dose if 
allowed to eat 
 
Lantus or NPH 
Insulin 
Take half  of 
your regularly 
prescribed dose
  
Take your 
regularly 
prescribed 
dose 
 Novolog Mix  
70/30, Novolin 
70/30, Premixed 
insulin  75/25 
Do not Take 
Resume 
regularly 
prescribed dose 
if allowed to eat
Resume regularly 
prescribed dose if 
allowed to eat 
 
Table 3. General guidelines for diabetic medications day of the colonoscopy 
www.intechopen.com
 
Colonoscopy 
 
20
Post procedure recovery: 
• You will be cared for by a nurse or a nurse’s aide and your vital signs monitored for 
about half-an-hour to an hour immediately after the procedure in the recovery area. 
This will also allow for most of the effects of the sedatives to wear off. 
• During this time, your doctor will talk to you about the results of your colonoscopy. 
If a biopsy was performed, the results are usually not available until a few days later 
as the sample (s) will be sent to the lab for analysis. He will also provide you with 
any pertinent additional information or instructions for follow-up.  
• You will be discharged home with your designated driver once you are feeling okay 
and are able to tolerate oral fluids without being nauseous or vomiting. If you are 
diabetic, it is a good idea to check your blood sugar before going home. 
• Plan to rest for the remainder of the day. 
• Eat foods that are easy to digest to minimize or avoid nausea and vomiting which is 
mostly due to the lingering side effects of the sedatives received. Examples are, toast, 
soup, light sandwich (e.g. grilled cheese), tea, and coffee. 
• You may occasionally feel some bloating or be flatulent. This is normal and should 
disappear within 24 hours. If you had a biopsy done, it is not uncommon to see some 
flecks of blood in your stool for a couple of days following your colonoscopy. This is 
usually dark in color. Call your physician if you have bright red blood in your stool, 
experiencing persistent nausea, vomiting, and abdominal pain or bloating. 
5. Safety and efficacy 
All colonoscopy bowel preparations are generally considered safe when properly dosed in 
individuals without contraindications to the specific product, but are not completely 
immune to the adverse reactions, and on occasion, severe negative outcomes. The safety of 
the bowel cleansing agent is related to the safety profile of the base agent, i.e, polyethylene 
glycol or sodium phosphate. The most commonly encountered side effects are bloating, 
abdominal pain, borborygmus, nausea, vomiting, dizziness, and fluid and electrolyte 
imbalance. Often the symptoms of nausea, vomiting and abdominal pain disappear once 
bowel movement commences. These symptoms have also been minimized and safety 
improved by splitting the dosages, adding adjuncts, administering low-volume preps, and 
increasing the interval time in-between dosages to 10-12 hours (ASGE, 2009; NGCH, 2006).  
Generally, the administration of isotonic  polyethylene glycol solutions do not cause 
significant physiologic changes in vital signs, individual’s weight, laboratory results 
(complete blood count, blood chemistries, and serum electrolytes). It has been safely 
administered in individuals with advanced liver and kidney failure, congestive heart failure, 
and fluid and electrolyte imbalances. Some concerns were raised with the use of some PEG 
solutions, HalfLytely, in particular, in patients taking angiotensin converting enzyme drugs 
(ACE) or potassium-sparing drugs such as aldactone, because of the small amount of 
potassium found in the solution. However, there were no clinical reports noted to date 
(ASGE, 2009; NGCH, 2006). 
Sodium phosphate, on the other hand, has been shown to alter both the macroscopic and 
microscopic (aphthoid erosions) mucosal lining of the intestine, which may mimic 
inflammatory bowel disease. This prep should then be avoided in individuals with or 
suspected to have inflammatory bowel disease. Serum electrolyte and fluid imbalances have 
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also been reported with sodium phosphate use. Hyperphosphatemia was seen in 40% of 
healthy individuals taking NaP. This could be significant for patients with renal failure. About 
20% of individuals taking NaP preps have developed hypokalemia, elevated blood urea 
nitrogen, increased plasma osmolality, decreased exercise endurance, significant 
hyponatremia, hypocalcemia, and seizures. A rare adverse event, nephrocalcinosis, has been 
reported in patients with acute renal failure (Balaban, D., 2008; Gonlusen, G., Akgun, H., Ertan, 
A., et al., 2006; NGCH, 2006). As a result, the Federal Drug Administration (FDA) has 
recommended that over-the-counter use of sodium phosphate solutions be discontinued and a 
black box warning be included in prescription products. Manufacturers of sodium phosphate 
products were also required to perform a “risk evaluation and mitigation strategy, including a 
post marketing trial,” to further assess occurrence of renal injury (ASGE, 2009). 
All bowel preps are contraindicated in individuals with known or suspected bowel 
obstruction, perforation or ileus. Bowel cleansing agents containing magnesium and 
phosphate should be used with caution or avoided in individuals with kidney failure. To 
minimize or avoid fluid and electrolyte imbalance, it is necessary to screen patients carefully 
and to instruct them to hydrate themselves, pre- and post-procedure. Intravenous fluids are 
usually given during the procedure.  
6. Conclusion 
Colonoscopy remains the gold standard in the screening and evaluation of the colon for 
colorectal disorders and diseases. For maximum visualization of the colon, it is imperative that 
the bowel is thoroughly cleaned. Several commercially prepared agents are available on the 
market, but the most commonly used ones are the polyethylene glycol and sodium phosphate 
preps. Adjuncts have also been recommended in addition to the main prep to make it easier to 
administer. The choice of an appropriate bowel cleansing agent is influenced by its safety, ease 
of administration and completion, cleansing effectiveness, patient tolerance, adverse effects, 
palatability, reimbursed by health insurance, will not interact with regularly prescribed 
medications, and cost. It should be tailored to every individual based on his or her state of 
health, comorbidities, and medications taken on a regular basis. Kidney function should be 
evaluated prior to choosing a bowel cleansing agent particularly in the elderly. Thus, careful 
screening of the patients prior to colonoscopy, prescribing the appropriate dose and bowel 
cleansing agent, patient education and adequate hydration before and after colonoscopy will 
help ensure the safety and efficacy of the procedure.  
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